Skip to main content

Accendra Health Inc

ACCH
Industry
Wholesale-Medical, Dental & Hospital Equipment & Supplies
SEC CIK
0000075252

In the last 90 days, Accendra Health Inc insiders filed 0 open-market purchases and 1 sale; no institution reported holding it in 13F filings for Q3 2026; no superinvestor holds it.

Other share classesACH

Key figures

Market capClose on Nov 16, 2026
$6.59M
Insider buysOpen market, last 90 days
0
Insider sellsLast 90 days, $4.05K in total
1
13F holdersQ3 2026
0
13F valueReported value at the end of Q3 2026
$0
Superinvestors holdingAt the end of Q3 2026
0

Price chart

From SEC filings, in USD.

Revenue, FY2025
$2.76B
−74.2% year over year
Net income, FY2025
-$1.10B
No comparable prior period
Free cash flow, FY2025
–
No comparable prior period
Revenue, Q3 FY2026
$601.8M
−13.7% year over year

Revenue flow, FY2025

Green is profit; orange is costs, expenses and taxes. Percentages are shares of revenue.

Net loss for FY2025: $1.10B (39.8% of revenue).

Superinvestors holding ACCH, Q3 2026

Go to the superinvestors tab

No superinvestor reported holding ACCH at the end of Q3 2026.

Latest insider trades

See all insider trades

Open-market purchases and sales by Accendra Health Inc insiders from Form 4, newest first.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Nov 17, 2026 (view filing)4:03 PM ETNov 161 dayBernocchi Perry AOther: former Chief Operating OfficerSSale−33.2K$0.122−$4.05K−10.6%280.8K after10b5-1
Aug 14, 2025 (view filing)8:23 PM ETAug 122 daysColiseum Capital Partners, L.P. and 4 others10% OwnerPPurchaseCommon Stock, par value $2 per share ("Common Stock")+720.0K$5.15+$3.71M+6.2%12.3M after
Aug 14, 2025 (view filing)8:23 PM ETAug 13-141 dayColiseum Capital Partners, L.P. and 4 others10% OwnerPPurchase+817.9K$5.37+$4.39M+6.7%13.1M after2 lots
Apr 10, 2025 (view filing)9:43 PM ETApr 82 daysColiseum Capital Partners, L.P. and 4 others10% OwnerPPurchaseCommon Stock, par value $2 per share ("Common Stock")+105.0K$7.96+$835.8K+0.9%11.3M after
Apr 10, 2025 (view filing)9:43 PM ETApr 9-101 dayColiseum Capital Partners, L.P. and 4 others10% OwnerPPurchase+305.0K$7.34+$2.24M+2.7%11.6M after2 lots
Apr 7, 2025 (view filing)8:21 PM ETApr 34 daysColiseum Capital Partners, L.P. and 4 others10% OwnerPPurchaseCommon Stock, par value $2 per share ("Common Stock")+160.0K$8.53+$1.36M+1.5%10.8M after
Apr 7, 2025 (view filing)8:21 PM ETApr 4-73 daysColiseum Capital Partners, L.P. and 4 others10% OwnerPPurchase+368.4K$7.94+$2.93M+3.4%11.2M after2 lots
Mar 4, 2025 (view filing)9:07 PM ETFeb 284 daysColiseum Capital Partners, L.P. and 4 others10% OwnerPPurchaseCommon Stock, par value $2 per share ("Common Stock")+1.74M$9.39+$16.3M+22.5%9.47M after
Mar 4, 2025 (view filing)9:07 PM ETMar 3-41 dayColiseum Capital Partners, L.P. and 4 others10% OwnerPPurchase+1.15M$9.58+$11.1M+12.2%10.6M after2 lots
Nov 25, 2024 (view filing)Nov 214 daysLeon Jonathan AEVP, Chief Financial OfficerSSale−5.28K$11.82−$62.4K−3.9%130.8K after10b5-1

Top 10 13F holders, Q3 2026

View all: Top 10 13F holders, Q3 2026

The largest institutional positions in Accendra Health Inc at the end of Q3 2026; share changes are against Q2 2026.

No institution reported holding ACCH in 13F filings for Q3 2026.